CLINICAL PREDICTORS OF LONG-TERM OUTCOME IN OBSESSIVE-COMPULSIVE DISORDER: Research Article: Predictors of Long-Term Outcome in OCD
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The purpose of this study was to investigate demographic and clinical factors associated with the long-term outcome of obsessive-compulsive disorder (OCD). METHODS: A hundred ninety-six previously untreated patients with DSM-IV criteria OCD completed a 12-week randomized open trial of group cognitive-behavioral therapy (GCBT) or fluoxetine, followed by 21 months of individualized, uncontrolled treatment, according to international guidelines for OCD treatment. OCD severity was assessed using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) at different times over the follow-up period. Demographics and several clinical variables were assessed at baseline. RESULTS: Fifty percent of subjects improved at least 35% from baseline, and 21.3% responded fully (final Y-BOCS score < or = 8). Worse prognosis was associated with earlier age at onset of OCD (P = 0.045), longer duration of illness (P = 0.001) presence of at least one comorbid psychiatric disorder (P = 0.001), comorbidity with a mood disorder (P = 0.002), higher baseline Beck-Depression scores (P = 0.011), positive family history of tics (P = 0.008), and positive family history of anxiety disorders (P = 0.008). Type of initial treatment was not associated with long-term outcome. After correction for multiple testing, the presence of at least one comorbid disorder, the presence of a depressive disorder, and duration of OCD remained significant. CONCLUSIONS: Patients under cognitive-behavioral or pharmacological treatment improved continuously in the long run, regardless of initial treatment modality or degree of early response, suggesting that OCD patients benefit from continuous treatment. Psychiatric comorbidity, especially depressive disorders, may impair the long-term outcome of OCD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048
A family study of obsessive–compulsive disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.76 · Cited by 1,022
Cognitive versus behavior therapy in the group treatment of obsessive–compulsive disorder
McLean, P. D., Whittal, M. L., Thordarson, D. S., Taylor, S., Söchting, I., Koch, W. J., Paterson, R., & Anderson, K. W. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.2.205 · Cited by 332 · cited 1×
“[54] One previous study,[55] however, suggested that CBT might be more effective when conducted individually.”
Obsessive-compulsive disorder phenotypes: implications for genetic studies
Miguel, E. C., Leckman, J. F., Rauch, S., do Rosario-Campos, M. C., Hounie, A. G., Mercadante, M. T., Chacon, P., & Pauls, D. L. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001617 · Cited by 282
Self-citationCognitive-behavioral group therapy in obsessive–compulsive disorder: a randomized clinical trial
Volpato Cordioli, A., Heldt, E., Braga Bochi, D., Margis, R., Basso de Sousa, M., Fonseca Tonello, J., Gus Manfro, G., & Kapczinski, F. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000070785 · Cited by 158
de Haan, E., van Oppen, P., van Balkom, A. J. L. M., Spinhoven, P., Hoogduin, K. A. L., & van Dyck, R. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09929.x · Cited by 136
Anderson, R. A., & Rees, C. S. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.01.016 · Cited by 132
Sousa, M. B., Isolan, L. R., Oliveira, R. R., Manfro, G. G., & Cordioli, A. V. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0717 · Cited by 110 · cited 2×
“However in that study, relatively lower doses of sertraline (up to a maximum of 100 mg/day) were used.[53] In the present study, group CBT was chosen due to its lower cost and previous evidence of similar response in comparison to individual CBT.”
MethodResultBelotto-Silva, C., Diniz, J. B., Malavazzi, D. M., Valério, C., Fossaluza, V., Borcato, S., Seixas, A. A., Morelli, D., Miguel, E. C., & Shavitt, R. G. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2011.08.008 · Cited by 85
Self-citation
Cited by
Manifesto for a European research network into Problematic Usage of the Internet
Fineberg, N., Demetrovics, Z., Stein, D., Ioannidis, K., Potenza, M., Grünblatt, E., Brand, M., Billieux, J., Carmi, L., King, D., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.08.004 · Cited by 334
Early intervention for obsessive compulsive disorder: An expert consensus statement
Fineberg, N. A., Dell'Osso, B., Albert, U., Maina, G., Geller, D., Carmi, L., Sireau, N., Walitza, S., Grassi, G., Pallanti, S., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.02.002 · Cited by 158
Self-citationO'Neill, J., & Feusner, J. (2015) · Psychology Research and Behavior Management · doi:10.2147/prbm.s75106 · Cited by 48
“58 Comorbid affective disorders, any comorbid psychiatric condition, and illness duration were associated with higher post-treatment OCD symptoms.”
Feusner, J. D., Moody, T., Lai, T. M., Sheen, C., Khalsa, S., Brown, J., Levitt, J., Alger, J., & O’Neill, J. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00074 · Cited by 46
“One study followed a cohort for 21months after a 12week randomized trial of groupCBTor fluoxetine (25).”
MethodKrompinger, J. W., Monaghan, S. C., Gironda, C. M., Garner, L. E., Crosby, J. M., Brennan, B. P., & Elias, J. A. (2017) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2017.10.001 · Cited by 17
Metadata
- Authors
- Jakubovski, E., Diniz, J. B., Valerio, C., Fossaluza, V., Belotto-Silva, C., Gorenstein, C., Miguel, E., & Shavitt, R. G.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2012-10-25
- Volume
- 30
- Issue
- 8
- Pages
- 763-772
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W1950933061
- Cited by
- 96
- References
- 9
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.